Key result
Transcatheter aortic valve replacement appears to be a promising option for inoperable or high-risk patients with pure aortic regurgitation, though surgery remains the gold standard.
Why the study?
Does TAVR provide a promising treatment option for inoperable/high-risk patients with pure aortic regurgitation?
Does TAVR provide a promising treatment option for inoperable/high-risk patients with pure aortic regurgitation?
TAVR may be a promising alternative to the gold-standard SAVR for inoperable or high-risk patients with pure aortic regurgitation.
Surgical treatment is the gold standard for pure aortic regurgitation (AR). In this study, transcatheter aortic valve replacement (TAVR) appears to be a promising option for inoperable/high-risk patients suffering pure AR. Long-term results and specific patient-level data are needed to better clarify the role of TAVR in pure AR treatment.
No takes yet. Share an insight, caveat, or question.
Tarantini et al. (2020) studied this question. Transcatheter aortic valve replacement appears to be a promising option for inoperable or high-risk patients with pure aortic regurgitation, though surgery remains the gold standard.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: